Site-Specific Covalent Immobilization of SMA-Stabilized ACE2 for SARS-CoV-2 Recognition and Drug Screening

Shuai Ge; Min Si; Qiumei Zhu; Yi Shan; Na Li; Yawen Wang; Hongliang Wang; Ge Luo; Huaizhen He; Langchong He

doi:10.1021/acsami.3c04383

journal article Jul 03, 2023

Site-Specific Covalent Immobilization of SMA-Stabilized ACE2 for SARS-CoV-2 Recognition and Drug Screening

Shuai Ge Min Si Qiumei Zhu Yi Shan

Na Li

Yawen Wang

Hongliang Wang

Ge Luo Huaizhen He Langchong He

ACS Applied Materials & Interfaces Vol. 15 No. 28 pp. 33348-33361 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acsami.3c04383

Topics

No keywords indexed for this article. Browse by subject →

References

49

[1]

Recent advances in screening active components from natural products based on bioaffinity techniques

Xiaofang Hou, Meng Sun, Tao Bao et al.

Acta Pharmaceutica Sinica B 10.1016/j.apsb.2020.04.016

[2]

10.1038/nrd.2017.146

[3]

10.1021/acsami.9b06838

[4]

Integrating enzyme immobilization and protein engineering: An alternative path for the development of novel and improved industrial biocatalysts

Claudia Bernal, Karen Rodríguez, Ronny Martínez

Biotechnology Advances 10.1016/j.biotechadv.2018.06.002

[5]

10.1021/bc4002823

[6]

10.1146/annurev-bioeng-092115-025322

[7]

Advances in cell membrane chromatography

Weina Ma, Rui Liu, Nan Wang et al.

Journal of Chromatography A 10.1016/j.chroma.2021.461916

[8]

10.1016/j.trac.2022.116601

[9]

He L. C. Drug Discoveries Ther. (2007)

[10]

10.1021/acsabm.0c00514

[11]

Targeting and Covalently Immobilizing the EGFR through SNAP-Tag Technology for Screening Drug Leads

Jia Fu, Qianqian Jia, Peida Liang et al.

Analytical Chemistry 10.1021/acs.analchem.1c01664

[12]

10.1016/j.ijbiomac.2018.11.219

[13]

10.1021/acs.analchem.2c03130

[14]

10.1007/s00216-014-7723-x

[15]

10.1016/bs.mie.2014.11.003

[16]

10.1021/acs.langmuir.0c00448

[17]

Oluwole A. O. Eur. Biophys. J. (2017)

[18]

10.1021/ja810046q

[19]

10.1177/2472555219867074

[20]

10.1021/acs.biomac.1c01166

[21]

10.1088/0957-4484/25/28/285101

[22]

10.1042/bsr20140171

[23]

10.1021/acs.nanolett.0c04911

[24]

10.1038/nprot.2016.070

[25]

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Carly G.K. Ziegler, Samuel J. Allon, Sarah K. Nyquist et al.

Cell 10.1016/j.cell.2020.04.035

[26]

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder et al.

Cell 10.1016/j.cell.2020.02.052

[27]

Cell entry mechanisms of SARS-CoV-2

Jian Shang, Yushun Wan, Chuming Luo et al.

Proceedings of the National Academy of Sciences 10.1073/pnas.2003138117

[28]

10.1007/s41061-021-00353-7

[29]

10.1128/aac.49.11.4721-4732.2005

[30]

10.1016/j.ejphar.2020.173455

[31]

10.1016/j.jpha.2021.12.003

[32]

10.1038/s41564-021-01041-4

[33]

10.1016/j.cbi.2021.109420

[34]

10.1016/j.virol.2021.05.009

[35]

10.1016/j.ejphar.2021.173897

[36]

10.1016/j.chroma.2017.04.053

[37]

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan, Yuanyuan Zhang, Yaning Li et al.

Science 10.1126/science.abb2762

[38]

10.1016/j.bbamem.2017.08.010

[39]

10.1016/j.chemphyslip.2018.11.011

[40]

10.1016/j.ijpharm.2019.118719

[41]

10.1002/anie.201406412

[42]

10.1021/acs.molpharmaceut.0c01090

[43]

10.1021/acsnano.0c08484

[44]

10.3389/fbioe.2022.1076749

[45]

10.1096/fj.202001792r

[46]

10.1016/j.antiviral.2020.104878

[47]

10.1128/mbio.03681-20

[48]

10.3390/biom11071048

[49]

10.1016/j.jmgm.2020.107697

Metrics

12

Citations

49

References

Details

Published: Jul 03, 2023
Vol/Issue: 15(28)
Pages: 33348-33361
License: View

Authors

S

Shuai Ge

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

M

Min Si

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

Q

Qiumei Zhu

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

Y

Yi Shan

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

N

Na Li

Department of Laboratory Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

Y

Yawen Wang

Department of Laboratory Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

H

Hongliang Wang

Department of Pathogenic Biology and Immunology, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

G

Ge Luo

Tianjin University, Tianjin 300072, China; Wooking Instruments Co., Ltd, Shandong 100096, China

H

Huaizhen He

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

L

Langchong He

School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China

Funding

National Natural Science Foundation of China Award: 81930096

Natural Science Basic Research Program of Shaanxi Province Award: 2023-JC-YB-679

Key Research and Development Projects of Shaanxi Province Award: 2022ZDXM-SF-03

Cite This Article

Shuai Ge, Min Si, Qiumei Zhu, et al. (2023). Site-Specific Covalent Immobilization of SMA-Stabilized ACE2 for SARS-CoV-2 Recognition and Drug Screening. ACS Applied Materials & Interfaces, 15(28), 33348-33361. https://doi.org/10.1021/acsami.3c04383

Site-Specific Covalent Immobilization of SMA-Stabilized ACE2 for SARS-CoV-2 Recognition and Drug Screening

You May Also Like